- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Declan Cobalt Inc. (“Declan” or the “Company”) (CSE:LAN) (FSE: DCR1) (OTCQB: DCNNF) is pleased to announce the appointment of Jamie Newall as a director, effective immediately.
Declan Cobalt Inc. (“Declan” or the “Company”) (CSE:LAN) (FSE: DCR1) (OTCQB: DCNNF) is pleased to announce the appointment of Jamie Newall as a director, effective immediately.
Mr. Newall, who has previously served as a member of the Company’s Advisory Board, is an experienced senior executive and non-executive director. He was the investment director of Intrepid Financial, an incubator of natural resource companies, for eight years, and has previously served as director and chief operating officer of Declan for two years. More recently, he has been interim chief executive officer of Conversis, one of the United Kingdom’s leading language service providers, and is voluntary chief executive officer of Oracle Cancer Trust, the U.K.’s largest head and neck cancer research charity. Mr. Newall has sat on the boards of many TSX-V-listed public companies, is a graduate of Cambridge University and holds a master’s degree in law.
Mr. Newall replaces Michael Curtis as a director of the Company, who has resigned as a director of the Company. The Company welcomes Mr. Newall in his new role and wishes to thank Mr. Curtis for his time and service over the years and wishes him the best in his future endeavors.
For additional information, please contact:
Declan Cobalt Inc.
Wayne Tisdale, President and CEO
T: (604) 639-4455
Source: globenewswire.com
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.